123
Participants
Start Date
February 6, 2019
Primary Completion Date
October 26, 2021
Study Completion Date
May 11, 2022
Apremilast
Tablets for oral administration
Medizinische Universitat Wien, Vienna
Hopital Universitaire Genevois - Beau-Sejour Hospital, Geneva
Frederiksberg Hospital, Frederiksberg
Copenhagen University Hospital Rigshospitalet, Glostrup Municipality
UZ Leuven, Leuven
Kantonsspital Aarau - KSA, Aarau
Aalborg Universitetshospital, Aalborg
Kantonsspital St Gallen, Sankt Gallen
NYU Langone Medical Center, New York
Hospital La Paz, Madrid
Malcom Randall VA Medical Center, Gainesville
Integral Rheumatology and Immunology Specialists, Plantation
Universitaetsklinikum Duesseldorf, Düsseldorf
Hospital Virgen de Macarena, Seville
Universitaetsklinikum Bonn, Bonn
Johann Wolfgang Goethe University Hospital, Frankfurt am Main
Universitaetsklinikum Tuebingen, Tübingen
Austin Regional Clinic, Austin
Azienda Ospedaliera Regionale San Carlo, Potenza/Matera
The Doctors of Saint John's Medical Group, Santa Monica
Inland Rheumatology Clinical Trials Inc, Upland
Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele Ospedale Vittorio Emanuele, Catania
Swedish Medical Center, Seattle
Research Institute of Rheumatology named after V.A.Nasonova, Moscow
Mechnikov North-Western State Medical University, Saint Petersburg
Udmurt Republic Republican Clinical Diagnostic Center, Izhevsk
Regional Clinical Hospital No 1 - Tyumen, Tyumen
LLC Medical Center Zdorovaya Semiya, Novosibirsk
University of Calgary - Cumming School of Medicine, Calgary
Alberta Rheumatology, Edmonton
Ottawa Hospital Research Institute, Ottawa
G.R.M.O. (Groupe de recherche en maladies osseuses) Inc., Québec
Hospital Santa Creu I Sant Pau, Barcelona
NHS Lothian, Western General Hospital, Edinburgh
The Leeds Teaching Hospitals NHS Trust - Chapel Allerton Hospital, Leeds
Southampton University Hospitals NHS Trust, Southampton
Lead Sponsor
Amgen
INDUSTRY